Crohn's Disease Clinical Trials
Crohn's Disease clinical trials study new biologics, small-molecule drugs, and treatment approaches for crohn's Disease and related immune or inflammatory conditions. Corterve gathers actively recruiting Crohn's Disease studies from ClinicalTrials.gov so you can browse by location and eligibility. This is general information, not medical advice — talk with your specialist before enrolling in a study.
Recruiting Crohn's Disease studies
- An Open-Label, Proof of Consent Study of Vorinostat for the Treatment of Mdoerate-to-Severe Crohn s Disease and Maintenance Therapy With UstekinumabNCT03167437PHASE1, PHASE2National Institute of Allergy and Infectious Diseases (NIAID)Crohn's DiseaseBethesda, Maryland
- Family Members at INcreased-risk for Developing Inflammatory Bowel DiseaseNCT06655415Massachusetts General HospitalInflammatory Bowel Disease (IBD)Boston, Massachusetts
- A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community SettingNCT06581328PHASE4TakedaUlcerative ColitisBirmingham, Alabama
- A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)NCT04844606PHASE3Eli Lilly and CompanyUlcerative ColitisSan Francisco, California
- A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's DiseaseNCT06226883PHASE2Morphic Therapeutic, Inc. (A Wholly Owned Subsidiary of Eli Lilly and Company)Inflammatory Bowel DiseasesLancaster, California
- A Study of Mirikizumab (LY3074828) in Pediatric Participants With Crohn's DiseaseNCT05509777PHASE3Eli Lilly and CompanyCrohn's DiseaseLos Angeles, California
- Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or OverweightNCT06937099PHASE3Eli Lilly and CompanyCrohn's DiseaseDothan, Alabama
- Longitudinal Immunophenotyping of Patients With Inflammatory Bowel DiseaseNCT07619547National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Inflammatory Bowel DiseaseBethesda, Maryland
- NOV-ERA - A Clinical Trial to Assess the Efficacy and Safety of Ontunisertib Compared to Placebo in Patients With Fibrostenosing Crohn's DiseaseNCT07683325PHASE2Agomab Spain S.L.U.Fibrostenotic Crohn's DiseaseBradenton, Florida
- Ketogenic and Carnivore (Lion) Diets for Inflammatory Bowel Disease and Rheumatoid ArthritisNCT07524244NAFuller Research FoundationRheumatoid Arthritis (RA)Charlottesville, Virginia
- Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative ColitisNCT07697456PHASE2AbbVieCrohn's DiseaseDothan, Alabama
- A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)NCT06430801PHASE3Merck Sharp & Dohme LLCCrohn's DiseaseDothan, Alabama
Crohn's Disease trials by state
Crohn's Disease trials by metro
Frequently asked questions
- How do I find recruiting Crohn's Disease clinical trials?
- Browse the actively recruiting Crohn's Disease studies listed on this page, or take an assessment to see trials you may qualify for based on your profile.
- Are Crohn's Disease clinical trials free to join?
- Costs, travel support, and any payment for taking part vary by study. Ask the study team what is covered before you decide to join.
- Who can take part in a Crohn's Disease clinical trial?
- Each study has its own eligibility criteria (for example age, disease stage, and prior treatments). This page is general information and not medical advice; discuss any specific trial with your healthcare provider to confirm whether it is appropriate for you.